This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Lifecell Corporation, University of Connecticut. Active years: 2011-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2018
Title: Innovations of Xiaohua Yu in Tissue Engineering
Introduction
Xiaohua Yu is an accomplished inventor based in Willimantic, CT (US). He has made significant contributions to the field of tissue engineering, particularly in the development of innovative devices and methods for treating defects in connective tissue. With a total of 3 patents, his work has the potential to greatly impact medical treatments and patient recovery.
Latest Patents
Xiaohua Yu's latest patents focus on enzyme-activated collagen and tissue matrices. These patents provide devices and methods for treating defects in connective tissue, along with methods for making such devices. The devices include enzyme-activated acellular tissue matrices that facilitate the regrowth of damaged tissue. This innovative approach represents a significant advancement in the field of regenerative medicine.
Career Highlights
Throughout his career, Xiaohua Yu has worked with notable organizations such as Lifecell Corporation and the University of Connecticut. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Xiaohua has collaborated with talented individuals, including Wenquan Sun and Mei Wei. These partnerships have fostered a creative environment that encourages innovation and the development of new technologies in tissue engineering.
Conclusion
Xiaohua Yu's contributions to tissue engineering through his patents and collaborations highlight his dedication to advancing medical science. His work continues to pave the way for new treatments that can improve patient outcomes and enhance the field of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile